We are live on
!
Find out more
Point72 Asset Management Portfolio holdings
AUM
$78.1B
1-Year Est. Return
55.25%
This Fund
S&P 500
This Quarter
Est. Return
+10.77%
1 Year Est. Return
+55.25%
3 Year Est. Return
+151.79%
5 Year Est. Return
+188.05%
10 Year Est. Return
+800.63%
AUM
$19.5B
AUM Growth
+$4.2B
(+27%)
Cap. Flow
+$3.06B
Cap. Flow
% of AUM
15.66%
Top 10 Holdings %
Top 10 Hldgs %
15.97%
Holding
1,184
New
406
Increased
253
Reduced
226
Closed
288
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$284M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$243M |
| 3 |
Eli Lilly
LLY
|
+$204M |
| 4 |
Meta Platforms (Facebook)
META
|
+$191M |
| 5 |
Microsoft
MSFT
|
+$134M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IMMU
Immunomedics Inc
IMMU
|
+$205M |
| 2 |
Merck
MRK
|
+$169M |
| 3 |
Canadian National Railway
CNI
|
+$131M |
| 4 |
NXP Semiconductors
NXPI
|
+$119M |
| 5 |
Fidelity National Information Services
FIS
|
+$119M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.23% |
| 2 | Technology | 20.39% |
| 3 | Consumer Discretionary | 13.52% |
| 4 | Financials | 8.95% |
| 5 | Communication Services | 7.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CIM
826
Chimera Investment
CIM
$1.06B
| $483K | ﹤0.01% |
+19,654
| New | +$523K |
|
|
VNE
827
DELISTED
Veoneer, Inc.
VNE
| $468K | ﹤0.01% |
+31,819
| New | +$384K |
|
828
Aaon
AAON
$7.86B
| $454K | ﹤0.01% |
11,297
-2,575
| -19% | -$98.7K |
|
829
Telephone and Data Systems
TDS
$4.1B
| $453K | ﹤0.01% |
+24,540
| New | +$516K |
|
830
Ambarella
AMBA
$3.64B
| $444K | ﹤0.01% |
+8,518
| New | +$412K |
|
|
FLG
831
Flagstar Bank National Association
FLG
$6B
| $437K | ﹤0.01% |
17,633
-105,291
| -86% | -$3.01M |
|
832
Sally Beauty Holdings
SBH
$1.6B
| $415K | ﹤0.01% |
47,779
-114,032
| -70% | -$1.37M |
|
833
Dyne Therapeutics
DYN
$4.84B
| $404K | ﹤0.01% |
+20,000
| New | +$439K |
|
834
ChargePoint
CHPT
$152M
| $390K | ﹤0.01% |
+1,250
| New | +$272K |
|
835
BJ's Restaurants
BJRI
$1.43B
| $388K | ﹤0.01% |
13,190
-52,556
| -80% | -$1.35M |
|
836
RadNet
RDNT
$5.41B
| $387K | ﹤0.01% |
25,236
-96,295
| -79% | -$1.52M |
|
|
SPPI
837
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $387K | ﹤0.01% |
+94,825
| New | +$361K |
|
838
Ardelyx
ARDX
$1.23B
| $384K | ﹤0.01% |
+73,091
| New | +$439K |
|
|
BMY.RT
839
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $383K | ﹤0.01% |
170,000
-3,627,564
| -96% | -$10.4M |
|
840
Exponent
EXPO
$3.28B
| $371K | ﹤0.01% |
5,147
-14,753
| -74% | -$1.17M |
|
841
Hilltop Holdings
HTH
$2.3B
| $370K | ﹤0.01% |
18,000
-802,495
| -98% | -$15.6M |
|
|
AZRE
842
DELISTED
Azure Power Global Limited
AZRE
| $369K | ﹤0.01% |
+12,368
| New | +$284K |
|
843
Chegg
CHGG
$116M
| $355K | ﹤0.01% |
+4,966
| New | +$366K |
|
|
YARW
844
Yarrow Bioscience, Inc. Common Stock
YARW
$25.6M
| $352K | ﹤0.01% |
+59
| New | +$344K |
|
845
International Bancshares
IBOC
$4.77B
| $346K | ﹤0.01% |
13,290
-710
| -5% | -$21.7K |
|
|
CADE
846
DELISTED
Cadence Bancorporation
CADE
| $339K | ﹤0.01% |
39,500
-93,900
| -70% | -$812K |
|
|
EVOP
847
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $338K | ﹤0.01% |
13,600
-11,100
| -45% | -$279K |
|
|
AMK
848
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $335K | ﹤0.01% |
+15,400
| New | +$388K |
|
849
Rapid7
RPD
$702M
| $320K | ﹤0.01% |
+5,219
| New | +$310K |
|
850
Myriad Genetics
MYGN
$305M
| $314K | ﹤0.01% |
+24,079
| New | +$305K |
|
Similar funds
CBU
BC
Point72 Asset Management's Q3 2020 Portfolio in Review
As of Q3 2020, Point72 Asset Management held 1,184 positions worth $19.5B, up 27% from $15.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Point72 Asset Management deployed $3.06B of net new capital in Q3 2020, opening 406 new positions and adding to 253 existing holdings. Its largest new stake was Palantir: 29,904,230 shares worth $284M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Immunomedics Inc, an estimated $205M trimmed.
- Point72 Asset Management's largest Q3 2020 buy was Palantir: 29,904,230 shares worth $284M.
- Point72 Asset Management added most to Alphabet (Google) Class A in Q3 2020, an estimated $243M increase.
- Point72 Asset Management's biggest Q3 2020 reduction was Immunomedics Inc, cutting an estimated $205M.
- Point72 Asset Management fully exited Salesforce in Q3 2020, selling an estimated $105M.
- Point72 Asset Management's ten largest holdings make up 16% of its $19.5B portfolio in Q3 2020.
- Point72 Asset Management opened 406 new positions and closed 288 in Q3 2020.
- Point72 Asset Management's portfolio value rose 27% quarter-over-quarter to $19.5B.
Based on Point72 Asset Management's 13F filing for Q3 2020, filed 16 Nov 2020.